摘要
目的研究终末期肾病老年患者采用血液透析或腹膜透析治疗的生存预后情况及其影响因素。方法该次研究对象为2017年1月—2019年12月期间在该院进行血液透析或腹膜透析治疗的终末期肾病老年患者100例,观察患者的生存预后情况,分析影响生存率的相关因素。结果100例进行血液透析或腹膜透析治疗的终末期肾病老年患者1年生存率为93.00%;生存患者年龄<70岁的比例(69.89%)、原发性疾病、透析时间(30.54±4.87)个月、血糖水平(5.11±0.65)mmol/L、HDL(1.66±0.42)mmol/L、Alb(37.05±5.27)g/L、hs-CRP(3.50±1.33)mmol/L与死亡患者进行比较,差异有统计学意义(χ^(2)=8.970、12.124,t=2.741、3.602、3.299、3.211、2.410,P<0.05);年龄、原发性疾病、透析时间、血糖水平、Alb、hs-CRP为影响终末期肾病老年患者透析治疗生存率的独立危险因素(P<0.05)。结论终末期肾病老年患者采用血液透析或腹膜透析治疗的的1年生存率较高,但多种因素会对患者的生存预后产生影响,因此需要根据影响因素及时采取相应的干预措施,以促进患者生存率的提高。
Objective To study the survival prognosis of elderly patients with end-stage renal disease treated with hemodialysis or peritoneal dialysis and its influencing factors.Methods The subjects of this study were 100 elderly patients with end-stage renal disease who underwent hemodialysis or peritoneal dialysis in the hospital from January 2017 to December 2019.The survival prognosis of the patients was observed and the relevant factors affecting survival rate were analyzed.Results The 1-year survival rate of 100 elderly patients with end-stage renal disease treated with hemodialysis or peritoneal dialysis was 93.00%.The proportion of survival patients with age<70 years(69.89%),primary disease,dialysis time(30.54±4.87)months,blood glucose level(5.11±0.65)mmol/L,HDL(1.66±0.42)mmol/L,Alb(37.05±5.27)g/L,hs-CRP(3.50±1.33)compared with the dead patients,the difference was statistically significant(χ^(2)=8.970,12.124,t=2.741,3.602,3.299,3.211,2.410,P<0.05).Age,primary disease,dialysis time,blood glucose level,Alb and hs-CRP were independent risk factors affecting the survival rate of elderly patients with end-stage renal disease treated by dialysis(P<0.05).Conclusion Elderly patients with end-stage renal disease who are treated with hemodialysis or peritoneal dialysis have a higher 1-year survival rate,but many factors will affect the survival and prognosis of patients.Therefore,it is necessary to take appropriate intervention measures in time according to influencing factors to promote the improvement of patient survival rate.
作者
袁苑
邹建华
YUAN Yuan;ZOU Jianhua(Department of Nephrology,Changshu Hospital Affiliated to Soochow University(Changshu First People's Hospital),Chagnshu,Jiangsu Province,215500 China)
出处
《系统医学》
2021年第21期106-109,共4页
Systems Medicine
基金
2020年常熟市卫生健康委员会科技计划项目(csws202015)。
关键词
终末期肾病
老年
血液透析
腹膜透析
生存预后
End-stage renal disease
Old age
Hemodialysis
Peritoneal dialysis
The prognosis of survival